New treatment for gastroesophageal reflux disease:Traditional Chinese medicine Xiaochaihu decoction

Gastroesophageal reflux disease(GERD)has a high prevalence worldwide.Li et al performed a well-designed study on the efficacy of modified Xiaochaihu decoction(MXD)for GERD,which showed that MXD is an optional therapy for GERD beyond proton pump inhibitors(PPIs).The herbal granule administration mode minimized the bias from traditional herbal formula in clinical trials.One limitation of that study was that it lacked records of side effects and rescue medication.As a chronic disease with recurrent symptoms,GERD rehabilitation requires prolonged observation of the clinical course with MXD therapy.

Modified Xiaochaihu Decoction for gastroesophageal reflux disease:A randomized double-simulation controlled trial

BACKGROUND Gastroesophageal reflux disease(GERD)has a high prevalence worldwide,and its incidence is increasing annually.Modified Xiaochaihu Decoction(MXD)could relieve the symptoms of GERD,but the effects of MXD on GERD manifestations and relapse prevention need to be further explained.Therefore,we performed a prospective,double-blind,and double-simulation study.AIM To verify the efficacy of MXD for GERD and its effect on esophageal motility.METHODS Using randomization,double-blinding,and a simulation design,288 participants with GERD were randomized to the treatment group and control group and received herbs(MXD)plus omeprazole simulation and omeprazole plus herbs simulation,respectively,for 4 wk.The GERD-Q scale score and esophageal manometry were measured at baseline,after treatment,and at 1 mo and 3 mo follow-up visits when medication was complete to evaluate recurrence indicators.RESULTS The GERD-Q scale score in both groups decreased significantly compared to those before treatment(P<0.01).However,no significant difference was observed between the two groups(P>0.05).Esophageal manometry showed that participants with lower esophageal sphincter pressure reduction and the proportion of ineffective swallowing(more than 50%)improved in both groups from baseline(P<0.01),especially in the treatment group(P<0.05).The percentage of small intermittent contractions,large intermittent contractions,and increased pre-phase contractions in the treatment group significantly improved compared with baseline(P<0.05)but did not improve in the control group(P>0.05).There was no significant difference between the groups after treatment(P>0.05).The percentage of weak esophageal contractility(distal contractile integral<450 mmHg·s·cm),improved in both groups(P<0.01),but no significant difference was observed between the groups after treatment(P>0.05).The relapse rate in the treatment group was lower than that in the control group at the 1 mo(P<0.01)and 3 mo follow-up(P<0.05).CONCLUSION MXD has a similar therapeutic effect to omeprazole in mild-to-moderate GERD.The therapeutic effect may be related to increased pressure in the lower esophageal sphincter and reduced ineffective swallowing.

Systematic evaluation and Meta-analysis of the efficacy of Xiaochaihu Decoction in the treatment of chronic superficial gastritis

Objective:To compare the effectiveness of Xiaochaihu Decoction(XCHD)or the modified XCHD combined with western medicine in the treatment of superficial gastritis.Methods:We collected the studies about XCHD or the modified XCHD combined with western medicine for superficial gastritis in China Biology Medicine(CBM)Database(2010-2018),China National Knowledge Infrastructure(CNKI)Database(2010-2018),VIP Database(2010-2018),Wanfang Database(2010-2018)and the Back Issues Database of Hebei University.The randomized controlled trials(RCTs)were included in this study.The literatures were independently extracted by two researchers and the Cochrane Review Handbook(version 5.1.0)was applied to assess the quality of included trials.Statistical analysis was performed with RevMan(version 5.3).Results:A total of 8 RCTs,including 732 cases,were included finally.Meta-analysis results showed that compared with the western medicine treatment group,XCHD or the modified XCHD combined with western medicine could improve the total effective rate[OR=4.67,95%CI(2.90,7.55),P<0.00001],physiological function[MD=10,95%CI(8.78,11.23),P<0.00001],role physical[MD=13.85,95%CI(11.19,16.51),P<0.00001],physical pain[MD=11.64,95%CI(9.05,14.23),P<0.00001],general health[MD=11.20,95%CI(9.52,12.88),P<0.00001],vitality[MD=13.46,95%CI(12.30,14.62),P<0.00001],social function[MD=19.20,95%CI(17.32,21.09),P<0.00001],affection function[MD=30.3,95%CI(28.99,31.62),P<0.00001],mental health[MD=9.80,95%CI(8.44,11.16),P<0.00001].Conclusion:XCHD or the modified XCHD combined with western medicine in the treatment of superficial gastritis has good performance in clinical efficacy and the improvement of quality of life.However,with several methodology problems existing in the included RCTs,the effectiveness of XCHD or the modified XCHD is still need more high-quality randomized,double-blind,placebo-controlled trials to further confirmed.

Analysis of the effect of Bupleurum on fever in Xiaochaihu Decoction based on network pharmacology

Objective:To explore the mechanism of Bupleurum on fever by means of network pharmacology,and to provide ideas for further experimental study.Methods:The effective components and targets of Xiaochaihu Decoction and Bupleurum were extracted by searching TCM systematic pharmacology database(TCMSP),and got to the effective components and targets of Xiaochaihu Decoction.By searching GeneCards database,disGeNET database,OMIM database and symmap database to extract the disease target of fever.And the"protein interaction network"was constructed with the protein interaction relationship in HINT database as the background network,and the GO enrichment analysis and KEGG pathway enrichment analysis were carried out on the targets by using R software and DAVID database.Results:726 kinds of effective components of Xiaochaihu Decoction were obtained from TCMSP database,including 215 kinds of effective components of Bupleurum,677 targets of Xiaochaihu Decoction and 516 targets of Bupleurum.A total of 7305 fever-related genes were obtained from the disease database,and 400 key targets of Bupleurum for fever treatment were obtained by mapping drug targets and disease targets GAPDH,AKT1,INS,IL-6 and VEGFA,are the targets with high node connectivity in PPI network.The results of GO enrichment of key targets by R software are cofactor binding and coenzyme binding.KEGG enrichment pathway of key targets involves infection,cancer,immune system diseases and so on.Conclusion:This study preliminarily verified the effect and mechanism of Bupleurum on fever,and provided reference for further study.

Xiaochaihu decoction alleviates viral pneumonia by regulating macrophage polarization

Background:In this investigation,we sought to evaluate the benefits of Xiaochaihu decoction(XCHD)on polyinosinic:polycytidylic acid-induced viral pneumonia in mice and elucidate its mechanisms of action.Method:A viral pneumonia model was established in mice using polyinosinic:polycytidylic acid,with mice being intragastrically administered different doses of XCHD.The benefits of XCHD therapy for mice with viral pneumonia were assessed by determining the weight ratio of lung tissue,wet-to-dry,overall protein concentrations,and total cell counts in bronchoalveolar lavage fluid,and hematoxylin and eosin staining of lung tissues.By determining the interleukin-1βlevels,interleukin-6,tumor necrosis factor-alpha,nitric oxide,interleukin-10,and interleukin-4,and the mRNA and protein expression of nitric oxide synthase 2,arginase-1,and macrophage mannose receptor 1 in bronchoalveolar lavage fluid,we assessed consequences of XCHD on macrophage polarization with mice suffering from viral pneumonia.Results:XCHD was found to significantly reduce lung tissue wet-to-dry and the total protein content and total number of cells of bronchoalveolar lavage fluid,while ameliorating pathological modifications to the lung tissues of rodents suffering from viral pneumonia,thereby indicating that this medicinal preparation has a healing impact on model mice with viral pneumonia.In addition,XCHD was found to reduce the magnitudes of interleukin-1β,interleukin-6,tumor necrosis factor-alpha,and nitric oxide and the mRNA and protein manifestation of nitric oxide synthase 2,and promote an increase in the levels of interleukin-10 and interleukin-4 and the mRNA and protein expression of arginase-1 and macrophage mannose receptor 1,thereby indicating that XCHD can favorably mediate polarization of macrophages in mice with viral pneumonia.Conclusion:XCHD has notable therapeutic effects on viral pneumonia in mice,the fundamental workings of action of which may be connected to regulation of macrophage polarization.

经典名方小柴胡汤抗抑郁研究进展

抑郁症属于中医“郁证”范畴,在新冠疫情背景下的抑郁症发病更是呈逐年上升趋势,中医药因其多途径、多层次、多靶点、多机制的作用方式在治疗抑郁症方面发挥着独特优势。小柴胡汤为治疗少阳证的经典名方,出自东汉张仲景的《伤寒杂病论》,其和解少阳且长于疏肝理气解郁,现代药理学研究也验证了其抗抑郁作用且临床应用广泛,但是关于小柴胡汤抗抑郁的机制还尚未有定论,因此作者基于临床应用、作用机制和化学成分对近十年来现有小柴胡汤抗抑郁的研究进行综述,探究小柴胡汤抗抑郁的机制,发现小柴胡汤抗抑郁的机制与单胺类神经递质及受体、HPA轴、脑源性神经营养因子(BDNF)及炎症反应等密切相关,且可能是协同作用的结果,为深入研究小柴胡汤治疗神经系统疾病及其机制提供理论依据。

补中益气汤合小柴胡汤治疗机械通气重症监护室获得性衰弱患者的临床疗效观察

[目的]探讨补中益气汤合小柴胡汤治疗机械通气重症监护室获得性衰弱(ICU-AW)的疗效。[方法]选择2019年10月—2022年10月河北省沧州中西医结合医院收治的82例行机械通气治疗的重症监护室获得性衰弱(ICU-AW)患者,随机数字表法将患者分为两组,每组各41例。对照组给予常规治疗,观察组在对照组基础上给予补中益气汤合小柴胡汤治疗14 d。比较两组疗效、机械通气时间、ICU住院时间、下床活动时间、中医证候积分、衰弱、肌力状态、运动耐力、日常生活能力以及并发症和不良反应差异。[结果]观察组治疗总有效率高于对照组(95.12%vs.73.17%,P<0.05),机械通气时间、重症监护室(ICU)住院时间、下床活动时间短于对照组(P<0.01),6 min步行距离、Barthel指数(BI)指数高于对照组(P<0.05),Borg评分、呼吸机相关性肺炎发生率低于对照组(P<0.05)。两组治疗后体倦乏力、食欲不振、胁胀作痛、情志抑郁、面色萎黄积分、心血管健康研究指数(CHS)评分均较治疗前降低(P<0.01),医学研究委员会(MRC)评分较治疗前增高(P<0.01),观察组治疗后上述中医证候积分、CHS评分低于对照组(P<0.01),MRC评分高于对照组(P<0.01)。[结论]与常规治疗比较,补中益气汤合小柴胡汤更有助于改善衰弱和疲劳症状,提高运动耐力和日常生活能力,临床疗效更显著。

从“和”之道谈小柴胡汤的临床应用

分析“和”的哲学含义及中医治病观之执中致和,探究中医“和”理论的思想内涵。通过以方证因的方式,分析小柴胡汤“和”之义在《伤寒杂病论》及临床应用中的体现。小柴胡汤“和”之义在于疏解少阳以和表里阴阳、通达三焦以和津液输布、调和气机以助斡旋运转,和洽配伍以治诸系统疾病。故表里不和、阴阳失衡、寒热错杂、津液失布、上下不通、气机失调等均可用小柴胡汤施治。

基于“脏腑别通”理论运用加味小柴胡汤结合捏脊法治疗心肌炎的实验研究

本研究旨在探明加味小柴胡汤结合捏脊法治疗心肌炎(MC)的作用机制。方法:将30只小鼠随机分成空白组、模型组、西药组、柴治组、捏治组、合治组共6组,每组5只。空白组不造模,其余各组均制成自身免疫性MC模型。各组施以相应处理7 d,结束后取心肌组织和血清分别检测肿瘤坏死因子-ɑ(TNF-ɑ)、白细胞介素-1β(IL-1β)、肌酸激酶同工酶(CK-MB)、心肌肌钙蛋白T(cTnT)、Toll样受体4(TLR4)、核因子-κB p65(NF-κB p65)、B淋巴细胞瘤-2基因(Bcl-2)、Bcl-2相关X蛋白(Bax)、半胱氨酸天冬氨酸蛋白酶-3(Caspase-3)的含量及心肌切片观察。结果:中医各治疗组对阻断心肌TLR4/NF-κB p65炎症通路及抑制心肌细胞凋亡的作用均优于西药组(P<0.05),且合治组在降低NF-κB p65、TNF-ɑ、Bax、Caspase-3和升高Bcl-2中的作用较其余治疗组为优(P<0.05);同时,与西药组比较,各中医治疗组心肌切片显示心肌细胞排列紊乱均有不同程度改善,心肌间隙炎细胞浸润较少,以合治组表现最佳。结论:加味小柴胡汤结合捏脊法可能通过抑制心肌TLR4/核因子-κB(NF-κB)信号通路阻止心肌炎症反应,同时抑制凋亡因子减少心肌凋亡来发挥对MC的治疗作用;二者结合运用能发挥良好的协同作用。

小柴胡汤现代临床应用及作用机制研究进展

小柴胡汤出自东汉医圣张仲景所编《伤寒论》,全方共奏疏肝解郁、扶正祛邪之效,主治少阳经证。对小柴胡汤的临床应用和作用机制两个方面的现代文献进行梳理,阐述了小柴胡汤在临床上广泛用于治疗神经系统疾病、消化系统疾病、呼吸系统疾病、泌尿系统疾病、内分泌疾病以及皮肤科疾病、耳鼻喉科疾病等病种,且获良效。同时从作用机制方面阐述了小柴胡汤治疗疾病的机制可能和抗炎、调节免疫、保护肝肾组织、调节血糖和血脂代谢等机制相关。

经典名方小柴胡汤研究进展

经方小柴胡汤出自张仲景的《伤寒论》,由柴胡、黄芩、生姜、半夏、人参、大枣、炙甘草等7味药组成。《伤寒论》载小柴胡汤应用广泛,不仅适用于少阳病证,还可应用于太阳、阳明、厥阴等多种类似病证中。现代实验研究证明,小柴胡汤含有皂苷类等多种有效成分,具有抗炎、调节免疫、抗抑郁、解热等药理作用。小柴胡汤在现代临床应用方面卓有成效,已广泛应用于肿瘤、肾脏、消化系统、肝脏、呼吸系统(新型冠状病毒感染、咳嗽)等疾病中。文章通过理论探讨、化学成分、药理作用、临床应用等4个方面对小柴胡汤研究现状进行综述,意在将小柴胡汤的传统六经辨证与现代临证相结合,以期为小柴胡汤后期深入探讨及临床应用提供参考依据。

小柴胡汤用治癌性疾病的研究

小柴胡汤是张仲景《伤寒论》中少阳百病之宗方,以“和”之法,双向调节以驱散邪气,临床应用广泛。肿瘤患者多见“小柴胡证”,随着中医药临床及药理学研究的不断深化,以小柴胡汤为基础方的方剂在治疗肝癌、胰腺癌、胃肠癌、肺癌以及癌性发热等疾病中效果明确。临床研究显示,其组方或复方能够提高放化疗以及靶向药物的效果、减轻毒副作用、改善患者的生存质量。药理学研究表明其组方药物的多种活性成分在抑制癌细胞生长增殖和促进其凋亡、激活肿瘤免疫效应方面均发挥了不同程度的抗肿瘤作用。

小柴胡汤治疗外感热病(邪郁少阳证) 的临床研究

目的探讨小柴胡汤治疗外感热病(邪郁少阳证)的效果。方法选取2021年7月至2023年11月本院收治的60例外感热病患者,按照奇偶顺序分为观察组与对照组。对照组采用西药治疗,观察组采用小柴胡汤治疗。比较两组治疗效果、症状消失时间、炎性因子。结果观察组总有效率为96.67%,高于对照组的73.33%(P<0.05)。观察组各项症状消失时间短于对照组(P<0.05)。治疗后,观察组TNF-α、IL-1β水平低于对照组(P<0.05)。结论小柴胡汤治疗外感热病(邪郁少阳证)的效果理想,可快速改善患者症状,抑制机体炎性因子。

补中益气汤联合小柴胡汤在脾肺气虚型肺结节中的应用

目的研究补中益气汤联合小柴胡汤用于脾肺气虚型肺结节的临床价值。方法选取脾肺气虚型肺结节患者90例,采用随机对照方法分为观察组(补中益气汤联合小柴胡汤治疗)及对照组(安慰剂治疗),每组45例。比较2组患者临床疗效。结果2组患者治疗前肺结节最大径、炎症因子水平、miR-200b及miR-200c差异无统计学意义。观察组治疗3个月后肺结节最大径、炎症因子水平均低于对照组(均P<0.05),miR-200b及miR-200c均高于对照组(均P<0.05)。2组患者均无明显并发症发生。结论补中益气汤联合小柴胡汤可降低脾肺气虚型肺结节最大径、炎症因子水平,提高miR-200b及miR-200c,疗效好且无明显不良反应。

《金匮要略》“郁冒”病证探究

郁冒是《金匮要略》产后三病之一,亦作症状出现于《伤寒论》厥病、厥阴病中,古今医家对其内涵认识不一。本文从文字学、文献溯源、以方测证三种角度对其内涵进行研究,认为“郁冒”二字本意是由闭郁所造成的昏冒症状。《黄帝内经》将郁冒内应于心,指神志异常,《伤寒论》中郁冒作为症状,指神昏、晕厥、郁闷等神志症状,为广义郁冒。《金匮要略》则将郁冒作为女性产后常见病,病因为“亡血复汗、寒多”,在产后津血亏虚情况下,邪气闭郁,阴阳不交,出现神志症状,以小柴胡汤为主方,为狭义郁冒。狭义郁冒与现代产褥期抑郁相吻合,女性经期、更年期生理特点与产褥期类似,亦常出现郁冒症状,这些疾病均可参照郁冒病治疗。

小柴胡汤治疗少阳失枢轻型复发性口腔溃疡患者的临床效果

目的探讨小柴胡汤治疗少阳失枢轻型复发性口腔溃疡(ROU)的临床疗效。方法采用前瞻性研究,选取2023年3月至2024年2月于广州市花都区妇幼保健院就诊的少阳失枢轻型ROU患者120例作为研究对象,采用随机数字表法分为对照组(60例)和观察组(60例)。对照组男20例、女40例,年龄(41.42±0.41)岁,病程(2.53±0.26)年,采用康复新液治疗;观察组男22例、女38例,年龄(39.78±0.66)岁,病程(2.11±0.71)年,采用康复新液联合小柴胡汤治疗。对比两组疗效、治疗7 d后溃疡愈合时间、激惹疼痛持续时间、中医症状积分变化及半年内复发情况。统计学方法采用t检验、χ^(2)检验。结果观察组治疗总有效率为88.3%(53/60),高于对照组的71.7%(43/60),差异有统计学意义(χ^(2)=5.208,P=0.022)。观察组口腔溃疡激惹疼痛持续时间、溃疡愈合时间均短于对照组[(2.67±0.34)d比(4.55±0.61)d、(4.24±0.21)d比(7.68±0.87)d],差异均有统计学意义(t=20.852、29.773,均P<0.05)。治疗7 d后,观察组中医症状积分差值为(5.66±0.82)分,低于对照组的(8.41±1.21)分,差异有统计学意义(t=14.573,P<0.001)。观察组患者治疗后6个月复发率为41.67%(25/60),低于对照组的80.00%(48/60),差异有统计学意义(χ^(2)=18.502,P<0.001)。结论小柴胡汤能有效治疗少阳失枢轻型ROU患者局部及全身症状,降低复发率。

从刘渡舟“古今接轨论”谈小柴胡汤在发热疾病中的应用

小柴胡汤出自《伤寒杂病论》,具有调和枢机、祛邪透热的功效,仲景用其治疗少阳发热、三阳合病发热、妇人经期发热等多种外感热病。经过后代医家的临床拓展,该方也可以治疗当今常见的发热疾病,如癌性发热、术后发热、不明原因高热等。“古今接轨论”是经方大家刘渡舟首先提出的,是将经方与时方合用的一种理论,文章以小柴胡汤为桥梁,对古今发热疾病进行联系接轨,这不仅丰富了“古今接轨论”的内涵,也拓宽了经方的现代应用。

咳喘定穴位贴敷联合小柴胡汤合半夏厚朴汤治疗痰浊阻肺证慢性阻塞性肺疾病患者的疗效观察

目的探讨咳喘定穴位贴敷联合小柴胡汤合半夏厚朴汤治疗痰浊阻肺证慢性阻塞性肺疾病(Chronic obstructive pulmonary disease,COPD)患者的临床疗效。方法选取2020年9月—2022年10月期间海南医学院第二附属医院收治的痰浊阻肺证COPD患者144例,按随机数字表法分为西药组、中药组、中药联合贴敷组,每组各48例。西药组采取常规西医治疗,中药组在西药基础上采取小柴胡汤合半夏厚朴汤治疗,中药联合贴敷组在常规西医基础上采取咳喘定穴位贴敷及小柴胡汤合半夏厚朴汤。治疗4周后,观察比较3组患者临床疗效、不良反应发生率、疾病复发率及治疗前后中医证候积分、肺功能[第1秒用力呼气容积(Forced expiratory volume for 1 second,FEV_(1))、用力肺活量(Forced vital capacity,FVC)、FEV_(1)/FVC]、康复效果[慢性阻塞性肺疾病评估测试量表(Chronic obstructive Pulmonary Disease Assessment Test Scale,CAT)、呼吸困难程度评分(modified Medical Research Council,mMRC)、6 min步行距离试验(6 min walking distance test,6MWT)]。结果治疗后中药联合贴敷组总有效率93.75%(45/48)高于西药组77.08%(37/48)、中药组79.17%(38/48),差异有统计学意义(P<0.05)。治疗后3组患者中医证候痰多、喘息、咳嗽、倦怠乏力、腹胀纳呆、下肢水肿积分均较治疗前降低,差异有统计学意义(P<0.05),且中药联合贴敷组中医证候痰多、喘息、咳嗽、倦怠乏力、腹胀纳呆、下肢水肿积分均明显低于西药组、中药组,差异有统计学意义(P<0.05)。治疗后3组患者肺功能FEV_(1)、FVC、FEV_(1)/FVC指标均较治疗前升高,差异有统计学意义(P<0.05);且中药联合贴敷组肺功能FEV_(1)、FVC、FEV_(1)/FVC指标明显高于西药组、中药组,差异有统计学意义(P<0.05)。治疗后3组患者康复效果CAT、mMRC评分较治疗前降低,6MWT较治疗前延长,差异有统计学意义(P<0.05);且中药联合贴敷组康复效果CAT、mMRC评分均明显低于西药组、中药组,6MWT明显优于西药组、中药组,差异有统计学意义(P<0.05)。治疗期间,中药联合贴敷组不良反应发生率8.33%(4/48)与西药组6.25%(3/48)、中药组4.17%(2/48)比较,差异无统计学意义(P>0.05)。治疗6个月后中药联合贴敷组疾病复发率4.17%(2/48)低于西药组18.75%(9/48)、中药组16.67(8/48),差异有统计学意义(P<0.05)。结论联合采取咳喘定穴位贴敷及小柴胡汤合半夏厚朴汤治疗痰浊阻肺证COPD效果显著,可有效缓解患者临床症状,改善肺功能及机体运动耐力,利于提升疾病整体干预效果,降低疾病复发率,且具有安全性。

小柴胡汤治疗不孕症的研究进展

小柴胡汤是《伤寒论》中著名方剂,具有和解少阳、疏肝解郁、调和气血等功效,可以用来治疗外感、内伤杂病、妇人病等疾病,疗效良好。中医学认为不孕症的病机与肾精亏虚、肝气郁结等因素有关,针对“肝气郁结”这一病机,结合张机“但见一证便是,不必悉具”之宗旨,小柴胡汤常被临床用于治疗不孕症及其相关疾病。

小柴胡汤合炙甘草汤治疗新型冠状病毒感染相关性心肌炎临床研究

目的:探讨小柴胡汤合炙甘草汤干预新型冠状病毒(COVID-19)感染相关病毒性心肌炎(VMC)的临床疗效。方法:选取COVID-19相关VMC患者60例,采用随机对照原则分为对照组和观察组,各30例。对照组给予曲美他嗪、辅酶Q10、维生素C等治疗,观察组在此基础上加用小柴胡汤合炙甘草汤治疗,疗程均为4周。分别在治疗后2、4周,对比两组心肌损伤指标、心功能指标、炎症指标、心律失常疗效、中医症候疗效、不良事件发生率。结果:治疗后2、4周,观察组心肌损伤标志物肌酸激酶同工酶(CKMB)、肌钙蛋白(cTnI)、谷草转氨酶(AST)均优于对照组(均P<0.05);心功能指标N末端-B型利钠肽前体(NT-proBNP)、左室收缩指数(LVEF)、左室舒张期末径(LVEDD)优于对照组(均P<0.05);炎症指标C反应蛋白(CRP)、血沉(ESR)、白介素-6(IL-6)、铁蛋白(SF)、淋巴细胞计数(LY)优于对照组(均P<0.05)。观察组心律失常总有效率为70.00%和83.33%,高于对照组的46.67%和63.33%(均P<0.05);观察组中医症候总有效率为76.67%和93.33%,高于对照组的56.67%与70.00%(均P<0.05)。结论:小柴胡汤合炙甘草汤治疗COVID-19相关VMC,可改善患者心肌损伤,保护心脏功能,降低炎症反应,改善心律失常。